HELP WITH COVERAGE, COSTS, AND MORE
Teva is here to help from the very beginning of treatment with UZEDY. Whether you’re looking for financial assistance, nurse support, or just want tips for talking to your healthcare provider, we can help.
UZEDY is an FDA-approved, long-acting injectable (LAI) form of risperidone used to treat schizophrenia in adults.
Instead of taking a pill every day to help treat your schizophrenia symptoms, with UZEDY, you get 1 injection every 1 or 2 months. A doctor or nurse will give your injection of UZEDY in a healthcare center. You and your healthcare provider can discuss which dosing schedule is right for you.
UZEDY is an FDA-approved, long-acting injectable (LAI) form of risperidone used to treat schizophrenia in adults.
Instead of taking a pill every day to help treat your schizophrenia symptoms, with UZEDY, you get 1 injection every 1 or 2 months. A doctor or nurse will give your injection of UZEDY in a healthcare center. You and your healthcare provider can discuss which dosing schedule is right for you.
UZEDY is an FDA-approved, long-acting injectable (LAI) form of risperidone used to treat schizophrenia in adults.
Instead of taking a pill every day to help treat your schizophrenia symptoms, with UZEDY, you get 1 injection every 1 or 2 months. A doctor or nurse will give your injection of UZEDY in a healthcare center. You and your healthcare provider can discuss which dosing schedule is right for you.
1 injection taken once every month
3 injections taken on the same day once every 3 months
AJOVY is long-acting, so you can take it just 4x per year.†‡
†”Long-acting” means the results measured over a 12-week period following a 675 mg (225 mg x 3) subcutaneous (SC) dose.
‡Quarterly dosing is 675 mg administered as three 225 mg SC injections every 3 months. Monthly dosing is one 225 mg SC injection each month.
Dupidatat non proident
Lorem ipsum dolor sit amet,
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt
mollit anim id est laborum
| SYSTEM/ORGAN CLASS ADVERSE REACTION |
2 MG TO 8 MG PER DAY % (N=366) |
>8 MG TO 16 MG PER DAY % (N=198) |
PLACEBO % (N=225) |
|---|---|---|---|
| Cardiac disorders | |||
| Tachycardia | 1 | 3 | 0 |
| Eye disorders | |||
| Vision blurred | 3 | 1 | 1 |
| Gastrointestinal disorders | |||
| Nausea | 9 | 4 | 4 |
| Constipation | 8 | 9 | 6 |
| Dyspepsia | 8 | 6 | 5 |
| Dry mouth | 4 | 0 | 1 |
| Abdominal discomfort | 3 | 1 | 1 |
| Salivary hypersecretion | 2 | 1 | <1 |
| Diarrhea | 2 | 1 | 1 |
| General disorders | |||
| Fatigue | 3 | 1 | 0 |
| Chest pain | 2 | 2 | 1 |
| Asthenia | 2 | 1 | <1 |
| Infections and infestations | |||
| Nasopharyngitis | 3 | 4 | 3 |
| Upper respiratory tract infection | 2 | 3 | 1 |
| Sinusitis | 1 | 2 | 1 |
| Urinary tract infection | 1 | 3 | 0 |
| Investigations | |||
| Blood creatine phosphokinase increased | 1 | 2 | <1 |
| Heart rate increased | <1 | 2 | 0 |
| Musculoskeletal and connective tissue disorders | |||
| Back pain | 4 | 1 | 1 |
| Arthralgia | 2 | 3 | <1 |
| Pain in extremity | 2 | 1 | 1 |
| Nervous system disorders | |||
| Parkinsonism* | 14 | 17 | 8 |
| Akathisia* | 10 | 10 | 3 |
| Sedation | 10 | 5 | 2 |
| Dizziness | 7 | 4 | 2 |
| Dystonia* | 3 | 4 | 2 |
| Tremor* | 2 | 3 | 1 |
| Dizziness postural | 2 | 0 | 0 |
| Psychiatric disorders | |||
| Insomnia | 32 | 25 | 27 |
| Anxiety | 16 | 11 | 11 |
| Respiratory, thoracic, and mediastinal disorders | |||
| Nasal congestion | 4 | 6 | 2 |
| Dyspnea | 1 | 2 | 0 |
| Epistaxis | <1 | 2 | 0 |
| Skin and subcutaneous tissue disorders | |||
| Rash | 1 | 4 | 1 |
| Dry skin | 1 | 3 | 0 |
| Vascular disorders | |||
| Orthostatic hypotension | 2 | 1 | 0 |
* Parkinsonism includes extrapyramidal disorder, musculoskeletal stiffness, parkinsonism, cogwheel rigidity, akinesia, bradykinesia, hypokinesia, masked facies, muscle rigidity, and Parkinson’s disease. Akathisia includes akathisia and restlessness. Dystonia includes dystonia, muscle spasms, muscle contractions involuntary, muscle contracture, oculogyration, tongue paralysis. Tremor includes tremor and parkinsonian rest tremor.
Important safety information
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor
in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
officia deserunt mollit anim id est laborum.
Duis aute irure dolor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Approved use
- Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliquaa
- Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequata
- Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Proident, sunt in culpa qui officia deserunt mollit anim id est laborum
© 2024 Cephalon, Inc., a wholly-owned subsidiary of Teva Pharmaceuticals, Inc. USA.
GRX-41470 March 2024.
This site is intended for US consumers only.